China Pharma Holdings (CPHI) Exchange Rate Effect (2010 - 2026)
China Pharma Holdings (CPHI) reported Exchange Rate Effect of -$42021.0 for Q1 2026, down 682.37% on a YoY basis from $7215.5 in Q1 2025, and down 1189.76% quarter-over-quarter from $3856.0 in Q4 2025.
China Pharma Holdings (CPHI) Exchange Rate Effect (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Exchange Rate Effect for 17 years, with the latest figure at -$42021.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 682.37% year-over-year to -$42021.0; the trailing twelve-month figure through Mar 2026 stood at -$35400.0 (up 44.78% YoY), and the FY2025 full-year result was $1250.0, up 101.91% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$42021.0, down from $3856.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $50439.0 in Q4 2023, with the low at -$153626.0 in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$18930.3 across 5 years, with a median of -$5371.0 in 2025.
- The largest YoY upside for Exchange Rate Effect was 1283.72% in 2022 against a maximum downside of 3654.3% in 2022.
- China Pharma Holdings' Exchange Rate Effect stood at $3874.0 in 2022, then jumped by 1201.99% to $50439.0 in 2023, then plunged by 225.7% to -$63400.0 in 2024, then soared by 106.08% to $3856.0 in 2025, then slumped by 1189.76% to -$42021.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$42021.0 (Q1 2026), $3856.0 (Q4 2025), and $42392.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -42,021.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,021.00 |
| Mar 31, 2026 | -42,021.00 |
| Dec 31, 2025 | 3,856.00 |
| Dec 31, 2025 | 3,856.00 |
| Sep 30, 2025 | 42,392.00 |
| Sep 30, 2025 | 42,392.00 |
| Jun 30, 2025 | -39,627.00 |
| Jun 30, 2025 | -39,627.00 |
| Mar 31, 2025 | -5,371.00 |
| Mar 31, 2025 | -5,371.00 |
| Dec 31, 2024 | -63,400.00 |
| Dec 31, 2024 | -63,400.00 |
| Sep 30, 2024 | 10,243.00 |
| Sep 30, 2024 | 10,243.00 |
| Jun 30, 2024 | -5,584.00 |
| Jun 30, 2024 | -5,584.00 |
| Mar 31, 2024 | -6,655.00 |
| Mar 31, 2024 | -6,655.00 |
| Dec 31, 2023 | 50,439.00 |
| Dec 31, 2023 | 50,439.00 |